The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma

Journal of Cutaneous Pathology

Volumn 28, Issue 10, 2001, Pages 520-524

  Sigel, Jessica E ^a   Skacel, Marek ^a   Bergfeld, Wilma F ^a   House, Nancy S ^b   Rabkin, Michael S ^b   Goldblum, John R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Rabkin Dermatopathology Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ARTICLE; CELL DIFFERENTIATION; CELL JUNCTION; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; RATING SCALE; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATINS; PREDICTIVE VALUE OF TESTS; SKIN NEOPLASMS;

EID: 0034748975     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2001.281005.x     Document Type: Article

References (20)

1. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma
2. Squamous cell carcinoma
3. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of skin, ear, and lip
4. The many faces of squamous cell carcinoma
5. Clinicopathologic variants of cutaneous squamous cell carcinoma
6. Cytokeratin profile of spindle cell squamous carcinoma
7. Cytokeratins in normal lung and lung carcinomas. I. Adenocarcinomas, squamous cell carcinomas and cultured cell lines
8. Anti-cytokeratin 5/6: A positive marker for epithelioid mesothelioma
9. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratins 5/6, calretinin, and CD44H in Distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura
10. Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma
11. Desmoplastic melanoma
12. Desmoplastic malignant melanoma
13. Desmoplastic and spindle-cell malignant melanoma: An immunohistochemical study
14. Melan-A, a new melanocytic differentiation marker
15. Expression of Melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
16. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors
17. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics
18. Cutaneous leiomyosarcoma
19. Atypical fibroxanthoma of the skin: A clinicopathologic study of 140 cases
20. Atypical fibroxanthoma: Multiple immunohistologic profiles